Asthma-related Dyselectrolytemia in Stable and Acute Exacerbation Chronic Obstructive Pulmonary Disease COPD Patients.

The Global Initiative for Chronic Obstructive Lung Disease (COLD) recently defined COPD as "A common preventable and treatable disease characterised by persistent airflow limitation that is typically progressive and associated with an increased chronic inflammatory response of the airways and lungs to noxious particles or gases." Despite the fact that COPD patients typically exhibit the symptoms of acute respiratory infections (productive cough, dyspnoea, etc.), there may be a number of metabolic derangements as a result of the illness process or the medicine supplied, such as dyselectrolytaemia. This study compares the levels of Sodium, Potassium, and Magnesium in patients with Stable COPD and COPD Exacerbation (AECOPD). Bronchial asthma and COPD (chronic obstructive pulmonary disease) are obstructive lung diseases that affect millions of individuals worldwide. Asthma is a significant global health issue affecting an estimated 300 million people. COPD is one of the primary causes of chronic morbidity and mortality, as well as one of the world's most significant public health issues. COPD is the fourth leading cause of death worldwide, and additional increases in its prevalence and mortality are anticipated. Although asthma and COPD share numerous similarities, they also have a number of differences. There are distinctions in their aetiology, symptoms, type of airway inflammation, inflammatory cells, mediators, consequences of inflammation, therapeutic responsiveness, and course. This article aims to illustrate similarities and differences between severe asthma and COPD. Today, asthma and COPD are not completely curable, are not recognised and treated adequately, and therapy is continuing under development. But in the future, a greater understanding of pathology, appropriate identification and treatment, and possibly new drugs, will result in a vastly improved quality of life and decreased morbidity and mortality among these individuals.

Subscribe to access this work and thousands more
Overall Rating

0

5 Star
(0)
4 Star
(0)
3 Star
(0)
2 Star
(0)
1 Star
(0)
APA

Mahajan, D. (2022). Asthma-related Dyselectrolytemia in Stable and Acute Exacerbation Chronic Obstructive Pulmonary Disease COPD Patients.. Afribary. Retrieved from https://afribary.com/works/asthma-related-dyselectrolytemia-in-stable-and-acute-exacerbation-chronic-obstructive-pulmonary-disease-copd-patients

MLA 8th

Mahajan, Dr Shivam "Asthma-related Dyselectrolytemia in Stable and Acute Exacerbation Chronic Obstructive Pulmonary Disease COPD Patients." Afribary. Afribary, 05 Oct. 2022, https://afribary.com/works/asthma-related-dyselectrolytemia-in-stable-and-acute-exacerbation-chronic-obstructive-pulmonary-disease-copd-patients. Accessed 20 Apr. 2024.

MLA7

Mahajan, Dr Shivam . "Asthma-related Dyselectrolytemia in Stable and Acute Exacerbation Chronic Obstructive Pulmonary Disease COPD Patients.". Afribary, Afribary, 05 Oct. 2022. Web. 20 Apr. 2024. < https://afribary.com/works/asthma-related-dyselectrolytemia-in-stable-and-acute-exacerbation-chronic-obstructive-pulmonary-disease-copd-patients >.

Chicago

Mahajan, Dr Shivam . "Asthma-related Dyselectrolytemia in Stable and Acute Exacerbation Chronic Obstructive Pulmonary Disease COPD Patients." Afribary (2022). Accessed April 20, 2024. https://afribary.com/works/asthma-related-dyselectrolytemia-in-stable-and-acute-exacerbation-chronic-obstructive-pulmonary-disease-copd-patients

Document Details
Field: Internal Medicine Type: Paper 9 PAGES (1500 WORDS) (pdf)